Detalles de la búsqueda
1.
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation.
J Thromb Thrombolysis
; 57(1): 1-10, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37530955
2.
Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population.
J Thromb Thrombolysis
; 48(2): 240-249, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30924051
3.
Tolerability of central nervous system symptoms among HIV-1 infected efavirenz users: analysis of patient electronic medical record data.
AIDS Care
; 29(8): 1067-1073, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28147708
4.
Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice.
J Clin Gastroenterol
; 50(2): 169-74, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26018133
5.
Risk of cardiovascular events among patients with HIV treated with atazanavir-containing regimens: a retrospective cohort study.
BMC Infect Dis
; 16: 492, 2016 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27643691
6.
Correction to: Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS Medicare population.
J Thromb Thrombolysis
; 51(2): 552-558, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32564179
7.
Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences.
Adv Ther
; 40(4): 1705-1735, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811795
8.
Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer.
J Immunother Cancer
; 11(1)2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36657815
9.
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease.
Thromb Haemost
; 122(6): 926-938, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34963185
10.
Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19.
Curr Med Res Opin
; 38(11): 1891-1896, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36000258
11.
Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding.
PLoS One
; 17(9): e0274969, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36149864
12.
Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysis.
Curr Med Res Opin
; 38(12): 2131-2140, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35993487
13.
Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
JAMA Netw Open
; 5(8): e2229333, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36044214
14.
Erratum to: Risk of cardiovascular events among patients with HIV treated with atazanavircontaining regimens: a retrospective cohort study.
BMC Infect Dis
; 16(1): 547, 2016 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27717332
15.
Effectiveness and safety of apixaban, LMWH, and warfarin among high-risk subgroups of VTE patients with active cancer.
Curr Med Res Opin
; 37(9): 1467-1482, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34030541
16.
Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity.
J Clin Med
; 10(2)2021 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33429844
17.
Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.
Thromb Res
; 198: 163-170, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33348190
18.
Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status.
Adv Ther
; 38(11): 5519-5533, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34570310
19.
Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis.
Thromb Haemost
; 121(3): 383-395, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33171521
20.
Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients.
Therap Adv Gastroenterol
; 14: 1756284821997352, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33815568